» Articles » PMID: 39329997

The Role of Artificial Intelligence on Tumor Boards: Perspectives from Surgeons, Medical Oncologists and Radiation Oncologists

Abstract

The integration of multidisciplinary tumor boards (MTBs) is fundamental in delivering state-of-the-art cancer treatment, facilitating collaborative diagnosis and management by a diverse team of specialists. Despite the clear benefits in personalized patient care and improved outcomes, the increasing burden on MTBs due to rising cancer incidence and financial constraints necessitates innovative solutions. The advent of artificial intelligence (AI) in the medical field offers a promising avenue to support clinical decision-making. This review explores the perspectives of clinicians dedicated to the care of cancer patients-surgeons, medical oncologists, and radiation oncologists-on the application of AI within MTBs. Additionally, it examines the role of AI across various clinical specialties involved in cancer diagnosis and treatment. By analyzing both the potential and the challenges, this study underscores how AI can enhance multidisciplinary discussions and optimize treatment plans. The findings highlight the transformative role that AI may play in refining oncology care and sustaining the efficacy of MTBs amidst growing clinical demands.

Citing Articles

The data scientist as a mainstay of the tumor board: global implications and opportunities for the global south.

Tan M, Lichlyter D, Maravilla N, Schrock W, Ting F, Choa-Go J Front Digit Health. 2025; 7:1535018.

PMID: 39981102 PMC: 11839724. DOI: 10.3389/fdgth.2025.1535018.


Clinical and Pathological Staging Discrepancies in Laryngeal Cancer: A Systematic Review.

Pecorari G, Lorenzi A, Caria M, Motatto G, Riva G Cancers (Basel). 2025; 17(3).

PMID: 39941822 PMC: 11815896. DOI: 10.3390/cancers17030455.


Utility of Artificial Intelligence for Decision Making in Thoracic Multidisciplinary Tumor Boards.

Zabaleta J, Aguinagalde B, Lopez I, Fernandez-Monge A, Lizarbe J, Mainer M J Clin Med. 2025; 14(2).

PMID: 39860405 PMC: 11765867. DOI: 10.3390/jcm14020399.


Progress and Challenges in Integrating Nutritional Care into Oncology Practice: Results from a National Survey on Behalf of the NutriOnc Research Group.

De Felice F, Malerba S, Nardone V, Salvestrini V, Calomino N, Testini M Nutrients. 2025; 17(1.

PMID: 39796623 PMC: 11722632. DOI: 10.3390/nu17010188.

References
1.
Zhou M, Leung A, Echegaray S, Gentles A, Shrager J, Jensen K . Non-Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications. Radiology. 2017; 286(1):307-315. PMC: 5749594. DOI: 10.1148/radiol.2017161845. View

2.
Chen Z, Lin L, Wu C, Li C, Xu R, Sun Y . Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine. Cancer Commun (Lond). 2021; 41(11):1100-1115. PMC: 8626610. DOI: 10.1002/cac2.12215. View

3.
Park Y, Chae H . The Fidelity of Artificial Intelligence to Multidisciplinary Tumor Board Recommendations for Patients with Gastric Cancer: A Retrospective Study. J Gastrointest Cancer. 2023; 55(1):365-372. PMC: 11096204. DOI: 10.1007/s12029-023-00967-8. View

4.
Hashimoto D, Rosman G, Rus D, Meireles O . Artificial Intelligence in Surgery: Promises and Perils. Ann Surg. 2018; 268(1):70-76. PMC: 5995666. DOI: 10.1097/SLA.0000000000002693. View

5.
Marano L, Ricci A, Savelli V, Verre L, Di Renzo L, Biccari E . From digital world to real life: a robotic approach to the esophagogastric junction with a 3D printed model. BMC Surg. 2019; 19(1):153. PMC: 6814977. DOI: 10.1186/s12893-019-0621-6. View